Browsing by Author Yupa Sabmee
Showing results 1 to 7 of 7
| Issue Date | Title | Author(s) |
| 1-Jul-2021 | Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP<inf>gen</inf> or combined TdaP<inf>gen</inf> vaccines | Punnee Pitisuttithum; Jittima Dhitavat; Chukiat Sirivichayakul; Arom Pitisuthitham; Yupa Sabmee; Pailinrut Chinwangso; Chawanee Kerdsomboon; Librada Fortuna; Jane Spiegel; Mukesh Chauhan; Indrajeet Kumar Poredi; Anita H.J. van den Biggelaar; Wassana Wijagkanalan; Simonetta Viviani; Souad Mansouri; Hong Thai Pham; Faculty of Tropical Medicine, Mahidol University; Ltd. |
| 1-Nov-2018 | Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial | Punnee Pitisuttithum; Kulkanya Chokephaibulkit; Chukiat Sirivichayakul; Sirintip Sricharoenchai; Jittima Dhitavat; Arom Pitisuthitham; Wanatpreeya Phongsamart; Kobporn Boonnak; Keswadee Lapphra; Yupa Sabmee; Orasri Wittawatmongkol; Mukesh Chauhan; Wassana Wijagkanalan; Greanggrai Hommalai; Librada Fortuna; Pailinrut Chinwangso; Indrajeet Kumar Poredi; Anita H.J. van den Biggelaar; Hong Thai Pham; Simonetta Viviani; Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University; BioNet-Asia Co. |
| 1-Jan-2014 | Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblinding | Kessuda Khowsroy; Jittima Dhitavat; Yupa Sabmee; Pataramon Laowarakul; Jutarat Wattanakitwichai; Jiraporn Auetian; Kannika Lothong; Roongtip Boondao; Sarawan Maythaarttaphong; Sunee Yaemwong; Jean Louis Excler; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Mahidol University; US Military HIV Research Program; Thailand Ministry of Public Health |
| 1-Jan-2018 | A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial | Sirintip Sricharoenchai; Chukiat Sirivichayakul; Kulkanya Chokephaibulkit; Punnee Pitisuttithum; Jittima Dhitavat; Arom Pitisuthitham; Wanatpreeya Phongsamart; Kobporn Boonnak; Keswadee Lapphra; Yupa Sabmee; Orasri Wittawatmongkol; Pailinrut Chinwangso; Indrajeet Kumar Poredi; Jean Petre; Pham Hong Thai; Simonetta Viviani; Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University; BioNet-Asia Co. |
| 4-Nov-2013 | Issues in women's participation in a phase III community HIV vaccine trial in Thailand | Jaranit Kaewkungwal; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirasak Khamboonruang; Prayura Kunasol; Pravan Suntharasamai; Swangjai Pungpak; Sirivan Vanijanonta; Valai Bussaratid; Wirach Maek-A-Nantawat; Jittima Dhitavat; Prasert Thongcharoen; Rungrawee Pawarana; Yupa Sabmee; Mike W. Benenson; Patricia Morgan; Robert J. O'Connell; Jerome Kim; Mahidol University; Thailand Ministry of Public Health; Armed Forces Research Institute of Medical Sciences, Thailand; U.S. Military HIV Research Program |
| 1-Apr-2020 | Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial | Punnee Pitisuttithum; Sorachai Nitayaphan; Suwat Chariyalertsak; Jaranit Kaewkungwal; Peter Dawson; Jittima Dhitavat; Benjaluck Phonrat; Siriwat Akapirat; Nicos Karasavvas; Lindsay Wieczorek; Victoria Polonis; Michael A. Eller; Poonam Pegu; Dohoon Kim; Alexandra Schuetz; Surat Jongrakthaitae; Yingjun Zhou; Faruk Sinangil; Sanjay Phogat; Carlos A. Diazgranados; James Tartaglia; Elizabeth Heger; Kirsten Smith; Nelson L. Michael; Jean Louis Excler; Merlin L. Robb; Jerome H. Kim; Robert J. O'Connell; Sandhya Vasan; Arom Pitisuthitham; Yupa Sabmee; Narongrid Sirisopana; Chirapa Eamsila; Prapaporn Savaraj; Wanlaya Labwech; Siriluck Teerachia; Nuntisa Chotirosniramit; Taweewat Supindham; Boonlure Pruenglampoo; Patcharaphan Sugandhavesa; Natthapol Kosashunhanan; Oranitcha Kaewthip; Piyathida Sroysuwan; Pawinee Jarujareet; Silvia Ratto-Kim; Sebastian Molnar; Jesse Schoen; Nampueng Churikanont; Saowanit Getchalarat; Nongluck Sangnoi; Bessara Nuntapinit; Anant Phramtong; Pornsuk V. Grandin; Sirinan Madnote; Surawach Rittiroongrad; Boot Kaewboon; Rapee Trichavaroj; Jiraporn Puangkaew; Somsak Chantakulkij; Phiromrat Rakyat; Pornchanok Panjapornsuk; Nipattra Tragonlugsana; Weerawan Chuenarom; Mark de Souza; Viseth Ngauy; Nittaya Phanuphak; Nitiya Chomchey; Puttachard Saengtawan; Nipat Teeratakulpisarn; Rungsun Rerknimitr; Eugene Kroon; Carter A. Lee; Suchada Chinaworapong; GlaxoSmithKline SpA; International Vaccine Institute, Seoul; Sanofi Pasteur SA; The EMMES Corporation; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Walter Reed Army Institute of Research; Mahidol University; Chiang Mai University; US Army Medical Materiel Development Activity; Global Solutions for Infectious Diseases |
| 1-Mar-2022 | Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial | Punnee Pitisuttithum; Viravarn Luvira; Saranath Lawpoolsri; Sant Muangnoicharoen; Supitcha Kamolratanakul; Chaisith Sivakorn; Piengthong Narakorn; Somchaiya Surichan; Sumalee Prangpratanporn; Suttida Puksuriwong; Steven Lamola; Laina D. Mercer; Rama Raghunandan; Weina Sun; Yonghong Liu; Juan Manuel Carreño; Rami Scharf; Weerapong Phumratanaprapin; Fatima Amanat; Luc Gagnon; Ching Lin Hsieh; Ruangchai Kaweepornpoj; Sarwat Khan; Manjari Lal; Stephen McCroskery; Jason McLellan; Ignacio Mena; Marcia Meseck; Benjaluck Phonrat; Yupa Sabmee; Ratsamikorn Singchareon; Stefan Slamanig; Nava Suthepakul; Johnstone Tcheou; Narumon Thantamnu; Sompone Theerasurakarn; Steven Tran; Thanakrit Vilasmongkolchai; Jessica A. White; Nina Bhardwaj; Adolfo Garcia-Sastre; Peter Palese; Florian Krammer; Kittisak Poopipatpol; Ponthip Wirachwong; Richard Hjorth; Bruce L. Innis; Faculty of Tropical Medicine, Mahidol University; PATH Seattle; Thailand Government Pharmaceutical Organization; The University of Texas at Austin; Icahn School of Medicine at Mount Sinai; Nexelis |
